Skip to main content
Erschienen in: Infection 2/2021

14.12.2020 | COVID-19 | Original Paper Zur Zeit gratis

Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore

verfasst von: Chaminda J. Seneviratne, Preethi Balan, Kwan Ki Karrie Ko, Nadeeka S. Udawatte, Deborah Lai, Dorothy Hui Lin Ng, Indumathi Venkatachalam, Kheng Sit Lim, Moi Lin Ling, Lynette Oon, Bee Tin Goh, Xiang Ying Jean Sim

Erschienen in: Infection | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

One of the key approaches to minimize the risk of COVID-19 transmission would be to reduce the titres of SARS-CoV-2 in the saliva of infected COVID-19 patients. This is particularly important in high-risk procedures like dental treatment. The present randomized control trial evaluated the efficacy of three commercial mouth-rinse viz. povidone–iodine (PI), chlorhexidine gluconate (CHX) and cetylpyridinium chloride (CPC), in reducing the salivary SARS-CoV-2 viral load in COVID-19 patients compared with water.

Methods

A total of 36 SARS-CoV-2-positive patients were recruited, of which 16 patients were randomly assigned to four groups—PI group (n = 4), CHX group (n = 6), CPC group (n = 4) and water as control group (n = 2). Saliva samples were collected from all patients at baseline and at 5 min, 3 h and 6 h post-application of mouth-rinses/water. The samples were subjected to SARS-CoV-2 RT-PCR analysis.

Results

Comparison of salivary Ct values of patients within each group of PI, CHX, CPC and water at 5 min, 3 h and 6 h time points did not show any significant differences. However, when the Ct value fold change of each of the mouth-rinse group patients were compared with the fold change of water group patients at the respective time points, a significant increase was observed in the CPC group patients at 5 min and 6 h and in the PI group patients at 6 h.

Conclusion

The effect of decreasing salivary load with CPC and PI mouth-rinsing was observed to be sustained at 6 h time point. Within the limitation of the current study, as number of the samples analyzed, the use of CPC and PI formulated that commercial mouth-rinses may be useful as a pre-procedural rinse to help reduce the transmission of COVID-19.
ISRCTN (ISRCTN95933274), 09/09/20, retrospectively registered
Literatur
Metadaten
Titel
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore
verfasst von
Chaminda J. Seneviratne
Preethi Balan
Kwan Ki Karrie Ko
Nadeeka S. Udawatte
Deborah Lai
Dorothy Hui Lin Ng
Indumathi Venkatachalam
Kheng Sit Lim
Moi Lin Ling
Lynette Oon
Bee Tin Goh
Xiang Ying Jean Sim
Publikationsdatum
14.12.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 2/2021
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01563-9

Weitere Artikel der Ausgabe 2/2021

Infection 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.